🇺🇸 FDA
Pipeline program

Non-invasive ventilation

858612

Phase 2 other active

Quick answer

Non-invasive ventilation for Amyotrophic Lateral Sclerosis (ALS) is a Phase 2 program (other) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Amyotrophic Lateral Sclerosis (ALS)
Phase
Phase 2
Modality
other
Status
active

Clinical trials